Stabilizing gold nanoparticle bioconjugates in physiological conditions by PEGylation

Area of Science:

• Nanotechnology
• Materials Science
• Biomedical Engineering

Background:

• Gold nanoparticles (AuNPs) are crucial for drug delivery but suffer from poor stability in physiological environments.
• Loss of colloidal stability in AuNPs can trigger adverse biological reactions, hindering their therapeutic potential.
• Developing stable AuNP-based nanosystems is essential for effective drug delivery applications.

Purpose of the Study:

• To develop a methodology for enhancing the stability of gold nanoparticles (AuNPs) in physiological conditions.
• To create and characterize mixed layers of AuNPs with polyethylene glycol (PEG) and alkanethiols.
• To evaluate the stability of drug conjugation to these modified AuNPs.

Main Methods:

• Preparation of mixed self-assembled monolayers (SAMs) of PEG and alkanethiols on AuNPs.
• Characterization of the composition and conformation of the mixed layers using techniques like spectroscopy and microscopy.
• Assay development to quantify the stability of the linkage between the AuNP conjugates and a model drug.

Main Results:

• Successful implementation of a method to confer enhanced colloidal stability to AuNPs using PEGylation.
• Detailed protocols for preparing and characterizing the structure of PEG-alkanethiol mixed layers on AuNPs.
• Demonstration of methods to assess the stability of drug-nanoparticle conjugates under relevant conditions.

Conclusions:

• PEGylation significantly improves the stability of gold nanoparticles in physiological conditions.
• The described protocols provide a reliable framework for creating stable and well-characterized AuNP-drug conjugates.
• This work contributes to the development of more robust and reliable nanosystems for drug delivery.